{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:10:33Z","timestamp":1784830233814,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1124\/dmd.118.086132","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T22:26:07Z","timestamp":1557786367000},"page":"1156-1163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Catalytic Cleavage of Disulfide Bonds in Small Molecules and Linkers of Antibody\u2013Drug Conjugates"],"prefix":"10.1016","volume":"47","author":[{"given":"Donglu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Fourie-O\u2019Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Dragovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Pillow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack D.","family":"Sadowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Cass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis E.C.A.","family":"Hop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Cyrus","family":"Khojasteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.118.086132_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2017-09-806737","article-title":"A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma","volume":"131","author":"Amengual","year":"2018","journal-title":"Blood"},{"key":"10.1124\/dmd.118.086132_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/ars.2010.3620","article-title":"Control of mature protein function by allosteric disulfide bonds","volume":"14","author":"Azimi","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/dmd.118.086132_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-62703-541-5_11","article-title":"Engineering THIOMABs for site-specific conjugation of thiol-reactive linkers","volume":"1045","author":"Bhakta","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.118.086132_bib4","doi-asserted-by":"crossref","first-page":"11761","DOI":"10.1074\/jbc.270.20.11761","article-title":"Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols","volume":"270","author":"Bj\u00f6rnstedt","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.118.086132_bib5","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood-2014-01-549816","article-title":"Control of blood proteins by functional disulfide bonds","volume":"123","author":"Butera","year":"2014","journal-title":"Blood"},{"key":"10.1124\/dmd.118.086132_bib6","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1021\/jm3000328","article-title":"Disulfide prodrugs of albitiazolium (T3\/SAR97276): synthesis and biological activities","volume":"55","author":"Caldarelli","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.118.086132_bib7","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1111\/j.1538-7836.2006.02236.x","article-title":"Allosteric disulfide bonds in thrombosis and thrombolysis","volume":"4","author":"Chen","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1124\/dmd.118.086132_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/med.20137","article-title":"Design of anticancer prodrugs for reductive activation","volume":"29","author":"Chen","year":"2009","journal-title":"Med Res Rev"},{"key":"10.1124\/dmd.118.086132_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/bc900315y","article-title":"Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibody-maytansinoid conjugates","volume":"21","author":"Erickson","year":"2010","journal-title":"Bioconjug Chem"},{"key":"10.1124\/dmd.118.086132_bib10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/1354750X.2012.715672","article-title":"Glutathione levels in human tumors","volume":"17","author":"Gamcsik","year":"2012","journal-title":"Biomarkers"},{"key":"10.1124\/dmd.118.086132_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1517\/13543784.2011.573477","article-title":"The development of pyrrolobenzodiazepines as antitumour agents","volume":"20","author":"Hartley","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/dmd.118.086132_bib12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1089\/ars.2017.7134","article-title":"Multifaceted roles of glutathione and glutathione-based systems in carcinogenesis and anticancer drug resistance","volume":"27","author":"Hatem","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/dmd.118.086132_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0968-0004(03)00057-4","article-title":"Disulfide bonds as switches for protein function","volume":"28","author":"Hogg","year":"2003","journal-title":"Trends Biochem Sci"},{"issue":"Suppl 1","key":"10.1124\/dmd.118.086132_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1538-7836.2009.03364.x","article-title":"Contribution of allosteric disulfide bonds to regulation of hemostasis","volume":"7","author":"Hogg","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1124\/dmd.118.086132_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0076-6879(95)52023-6","article-title":"Thioredoxin and thioredoxin reductase","volume":"252","author":"Holmgren","year":"1995","journal-title":"Methods Enzymol"},{"key":"10.1124\/dmd.118.086132_bib16","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/bc400217g","article-title":"A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technology","volume":"24","author":"Jeffrey","year":"2013","journal-title":"Bioconjug Chem"},{"key":"10.1124\/dmd.118.086132_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cca.2008.06.020","article-title":"A rapid LC-FTMS method for the analysis of cysteine, cystine and cysteine\/cystine steady-state redox potential in human plasma","volume":"396","author":"Johnson","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1124\/dmd.118.086132_bib18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/acsmedchemlett.6b00421","article-title":"Next-generation antibody-drug conjugates (ADCs) for cancer therapy","volume":"7","author":"Junutula","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/dmd.118.086132_bib19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1021\/bc100480a","article-title":"Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage","volume":"22","author":"Kellogg","year":"2011","journal-title":"Bioconjug Chem"},{"key":"10.1124\/dmd.118.086132_bib20","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1021\/cr300358b","article-title":"Disulfide-cleavage-triggered chemosensors and their biological applications","volume":"113","author":"Lee","year":"2013","journal-title":"Chem Rev"},{"key":"10.1124\/dmd.118.086132_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3460001","article-title":"Thioredoxin reductase","volume":"346","author":"Mustacich","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/dmd.118.086132_bib22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1021\/acs.bioconjchem.7b00791","article-title":"High-throughput cysteine scanning to identify stable antibody conjugation sites for maleimide- and disulfide-based linkers","volume":"29","author":"Ohri","year":"2018","journal-title":"Bioconjug Chem"},{"key":"10.1124\/dmd.118.086132_bib23","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1271\/bbb.110356","article-title":"Optimized method for determining free L-cysteine in rat plasma by high-performance liquid chromatography with the 4-aminosulfonyl-7-fluoro-2,1,3-benzoxadiazole conversion reagent","volume":"75","author":"Otani","year":"2011","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1124\/dmd.118.086132_bib24","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1021\/acs.molpharmaceut.8b00431","article-title":"Exploration of pyrrolobenzodiazepine (PBD)-dimers containing disulfide-based prodrugs as payloads for antibody-drug conjugates","volume":"15","author":"Pei","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.118.086132_bib25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1039\/C6SC01831A","article-title":"Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates","volume":"8","author":"Pillow","year":"2017","journal-title":"Chem Sci (Camb)"},{"key":"10.1124\/dmd.118.086132_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1158\/1535-7163.MCT-16-0641","article-title":"Modulating therapeutic activity and toxicity of pyrrolobenzodiazepine antibody-drug conjugates with self-immolative disulfide linkers","volume":"16","author":"Pillow","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/dmd.118.086132_bib27","doi-asserted-by":"crossref","first-page":"37423","DOI":"10.1074\/jbc.M506439200","article-title":"Redox imbalance in cystine\/glutamate transporter-deficient mice","volume":"280","author":"Sato","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.118.086132_bib28","doi-asserted-by":"crossref","first-page":"302ra136","DOI":"10.1126\/scitranslmed.aac9459","article-title":"A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo","volume":"7","author":"Saunders","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1124\/dmd.118.086132_bib29","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nchem.2635","article-title":"Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates","volume":"8","author":"Staben","year":"2016","journal-title":"Nat Chem"},{"issue":"23","key":"10.1124\/dmd.118.086132_bib36","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1021\/acs.analchem.6b03410","article-title":"Custom-Designed Affinity Capture LC-MS F(ab\u2019)2 Assay for Bio-transformation Assessment of Site-Specific Antibody Drug Conjugates","volume":"88","author":"Su","year":"2016","journal-title":"Analytical Chemistry"},{"key":"10.1124\/dmd.118.086132_bib30","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1016\/S0960-894X(02)00784-9","article-title":"Reductively activated disulfide prodrugs of paclitaxel","volume":"12","author":"Vrudhula","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.118.086132_bib31","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1021\/nl502044x","article-title":"Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines","volume":"14","author":"Wang","year":"2014","journal-title":"Nano Lett"},{"key":"10.1124\/dmd.118.086132_bib32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/acsmedchemlett.6b00233","article-title":"Linker immolation determines cell killing activity of disulfide-linked pyrrolobenzodiazepine antibody-drug conjugates","volume":"7","author":"Zhang","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/dmd.118.086132_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1535-7163.MCT-17-0697","article-title":"Intratumoral payload concentration correlates with the activity of antibody-drug conjugates","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/dmd.118.086132_bib34","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1080\/10717544.2017.1381201","article-title":"Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy","volume":"24","author":"Zhang","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1124\/dmd.118.086132_bib35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejmech.2017.08.010","article-title":"Prodrug strategy for cancer cell-specific targeting: a recent overview","volume":"139","author":"Zhang","year":"2017","journal-title":"Eur J Med Chem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562407908X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562407908X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.118.086132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:57:46Z","timestamp":1739905066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562407908X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S009095562407908X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.118.086132","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catalytic Cleavage of Disulfide Bonds in Small Molecules and Linkers of Antibody\u2013Drug Conjugates","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.118.086132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}